Cargando…
EMMY: The continued expansion of clinical applications of SGLT2 inhibitors
Introduction: Myocardial infarction (MI) is a challenging clinical and public health problem and is a leading cause of morbidity and mortality worldwide. Heart failure (HF) is a common sequela of acute myocardial infarction (AMI), with an incidence of up to 40% among hospitalized patients and has im...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Magdi Yacoub Heart Foundation
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988294/ https://www.ncbi.nlm.nih.gov/pubmed/36890845 http://dx.doi.org/10.21542/gcsp.2023.5 |